US Stock MarketDetailed Quotes

ELTX Elicio Therapeutics

Watchlist
  • 4.420
  • +0.080+1.84%
Trading Aug 26 09:30 ET
47.62MMarket Cap-1172P/E (TTM)

Elicio Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
40.47%10.92M
31.21%10.24M
50.61%35.75M
57.56%9.39M
86.67%10.77M
24.79%7.78M
7.81M
-6.84%23.73M
5.96M
5.77M
Selling and administrative expenses
-3.14%2.74M
15.55%2.68M
111.30%11.9M
93.60%3.24M
197.96%3.51M
137.87%2.83M
--2.32M
-25.36%5.63M
--1.67M
--1.18M
-General and administrative expense
-3.14%2.74M
15.55%2.68M
111.30%11.9M
93.60%3.24M
197.96%3.51M
137.87%2.83M
--2.32M
-25.36%5.63M
--1.67M
--1.18M
Research and development costs
65.45%8.18M
37.84%7.56M
31.74%23.85M
43.52%6.16M
58.15%7.26M
-1.92%4.94M
--5.48M
0.95%18.1M
--4.29M
--4.59M
Operating profit
-40.47%-10.92M
-31.21%-10.24M
-50.61%-35.75M
-57.56%-9.39M
-86.67%-10.77M
-24.79%-7.78M
-7.81M
6.84%-23.73M
-5.96M
-5.77M
Net non-operating interest income expense
113.04%88K
-39.76%-464K
80.58%-686K
297.30%73K
122.94%245K
36.74%-675K
-332K
-304.56%-3.53M
-37K
-1.07M
Non-operating interest income
251.28%137K
1,400.00%150K
473.85%373K
36.36%75K
2,360.00%246K
--39K
--10K
1,816.27%65K
--55K
--10K
Non-operating interest expense
-93.14%49K
-89.47%36K
-70.56%1.06M
-97.83%2K
-99.91%1K
-33.08%714K
--342K
310.41%3.6M
--92K
--1.08M
Total other finance cost
----
--578K
----
----
----
----
----
----
----
----
Other net income (expense)
303.92%3.61M
-1,138.89%-1.12M
231.07%1.24M
156.66%370K
63.33%-132K
893K
108K
-1,680.52%-943K
-653K
-360K
Gain on sale of security
1,148.10%3.61M
-1,141.67%-1.13M
166.77%631K
140.06%264K
92.50%-27K
--289K
--108K
-1,684.30%-945K
---659K
---360K
Special income (charges)
--0
--3K
30,150.00%605K
1,666.67%106K
---105K
--604K
--0
--2K
--6K
--0
-Less:Other special charges
----
----
-30,150.00%-605K
---1K
----
---604K
----
---2K
----
----
-Gain on sale of property,plant,equipment
--0
--3K
----
----
---105K
--0
--0
----
----
--0
Income before tax
4.37%-7.23M
-47.30%-11.83M
-24.77%-35.2M
-34.55%-8.95M
-48.07%-10.66M
-3.56%-7.56M
-8.03M
-6.85%-28.21M
-6.65M
-7.2M
Income tax
Net income
4.37%-7.23M
-47.30%-11.83M
-24.77%-35.2M
-34.55%-8.95M
-48.07%-10.66M
-3.56%-7.56M
-8.03M
-6.85%-28.21M
-6.65M
-7.2M
Net income continuous Operations
4.37%-7.23M
-47.30%-11.83M
-24.77%-35.2M
-34.55%-8.95M
-48.07%-10.66M
-3.56%-7.56M
---8.03M
-6.85%-28.21M
---6.65M
---7.2M
Minority interest income
Net income attributable to the parent company
4.37%-7.23M
-47.30%-11.83M
-24.77%-35.2M
-34.55%-8.95M
-48.07%-10.66M
-3.56%-7.56M
-8.03M
-6.85%-28.21M
-6.65M
-7.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.37%-7.23M
-47.30%-11.83M
-24.77%-35.2M
-34.55%-8.95M
-48.07%-10.66M
-3.56%-7.56M
-8.03M
-6.85%-28.21M
-6.65M
-7.2M
Basic earnings per share
75.48%-0.64
-25.07%-1.15
-158.18%-6.96
-46.60%-0.9318
-84.62%-1.27
-274.17%-2.61
-0.9195
-6.85%-2.6958
-0.6356
-0.6879
Diluted earnings per share
75.48%-0.64
-25.07%-1.15
-158.18%-6.96
-46.60%-0.9318
-84.62%-1.27
-274.17%-2.61
-0.9195
-6.85%-2.6958
-0.6356
-0.6879
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 40.47%10.92M31.21%10.24M50.61%35.75M57.56%9.39M86.67%10.77M24.79%7.78M7.81M-6.84%23.73M5.96M5.77M
Selling and administrative expenses -3.14%2.74M15.55%2.68M111.30%11.9M93.60%3.24M197.96%3.51M137.87%2.83M--2.32M-25.36%5.63M--1.67M--1.18M
-General and administrative expense -3.14%2.74M15.55%2.68M111.30%11.9M93.60%3.24M197.96%3.51M137.87%2.83M--2.32M-25.36%5.63M--1.67M--1.18M
Research and development costs 65.45%8.18M37.84%7.56M31.74%23.85M43.52%6.16M58.15%7.26M-1.92%4.94M--5.48M0.95%18.1M--4.29M--4.59M
Operating profit -40.47%-10.92M-31.21%-10.24M-50.61%-35.75M-57.56%-9.39M-86.67%-10.77M-24.79%-7.78M-7.81M6.84%-23.73M-5.96M-5.77M
Net non-operating interest income expense 113.04%88K-39.76%-464K80.58%-686K297.30%73K122.94%245K36.74%-675K-332K-304.56%-3.53M-37K-1.07M
Non-operating interest income 251.28%137K1,400.00%150K473.85%373K36.36%75K2,360.00%246K--39K--10K1,816.27%65K--55K--10K
Non-operating interest expense -93.14%49K-89.47%36K-70.56%1.06M-97.83%2K-99.91%1K-33.08%714K--342K310.41%3.6M--92K--1.08M
Total other finance cost ------578K--------------------------------
Other net income (expense) 303.92%3.61M-1,138.89%-1.12M231.07%1.24M156.66%370K63.33%-132K893K108K-1,680.52%-943K-653K-360K
Gain on sale of security 1,148.10%3.61M-1,141.67%-1.13M166.77%631K140.06%264K92.50%-27K--289K--108K-1,684.30%-945K---659K---360K
Special income (charges) --0--3K30,150.00%605K1,666.67%106K---105K--604K--0--2K--6K--0
-Less:Other special charges ---------30,150.00%-605K---1K-------604K-------2K--------
-Gain on sale of property,plant,equipment --0--3K-----------105K--0--0----------0
Income before tax 4.37%-7.23M-47.30%-11.83M-24.77%-35.2M-34.55%-8.95M-48.07%-10.66M-3.56%-7.56M-8.03M-6.85%-28.21M-6.65M-7.2M
Income tax
Net income 4.37%-7.23M-47.30%-11.83M-24.77%-35.2M-34.55%-8.95M-48.07%-10.66M-3.56%-7.56M-8.03M-6.85%-28.21M-6.65M-7.2M
Net income continuous Operations 4.37%-7.23M-47.30%-11.83M-24.77%-35.2M-34.55%-8.95M-48.07%-10.66M-3.56%-7.56M---8.03M-6.85%-28.21M---6.65M---7.2M
Minority interest income
Net income attributable to the parent company 4.37%-7.23M-47.30%-11.83M-24.77%-35.2M-34.55%-8.95M-48.07%-10.66M-3.56%-7.56M-8.03M-6.85%-28.21M-6.65M-7.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.37%-7.23M-47.30%-11.83M-24.77%-35.2M-34.55%-8.95M-48.07%-10.66M-3.56%-7.56M-8.03M-6.85%-28.21M-6.65M-7.2M
Basic earnings per share 75.48%-0.64-25.07%-1.15-158.18%-6.96-46.60%-0.9318-84.62%-1.27-274.17%-2.61-0.9195-6.85%-2.6958-0.6356-0.6879
Diluted earnings per share 75.48%-0.64-25.07%-1.15-158.18%-6.96-46.60%-0.9318-84.62%-1.27-274.17%-2.61-0.9195-6.85%-2.6958-0.6356-0.6879
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg